Response to Peptide Receptor Radionuclide Therapy in Pheocromocytomas and Paragangliomas: A Systematic Review and Meta-Analysis

Introduction. Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE and 90Y-DOTATOC showed efficacy in the metastatic setting of pheocromocytomas (PCCs) and paragangliomas (PGLs) where no standard therapies have been established. Background. A search of peer-reviewed and English articles...

Descripción completa

Detalles Bibliográficos
Autores principales: Marretta, Antonella Lucia, Ottaiano, Alessandro, Iervolino, Domenico, Bracigliano, Alessandra, Clemente, Ottavia, Di Gennaro, Francesca, Tafuto, Roberto, Santorsola, Mariachiara, Lastoria, Secondo, Tafuto, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964778/
https://www.ncbi.nlm.nih.gov/pubmed/36836029
http://dx.doi.org/10.3390/jcm12041494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9964778/
https://www.ncbi.nlm.nih.gov/pubmed/36836029
http://dx.doi.org/10.3390/jcm12041494

Ejemplares similares